Notified Body
For MedTech Regulatory Teams

Reduce Notified Body
questions before submission

Studia is the AI-powered Notified Body Readiness Platform. Evaluate your CER, CIP, Risk File, and PMCF the way a reviewer will, and surface the deficiencies before they cost you months.

See how it works

Designed around MDR, IVDR, MEDDEV, and ISO 14155 expectations.

3-9months saved per deficiency avoided
6+document types reviewed in parallel
100%findings traceable and explainable

What will the Notified Body challenge?

Before every submission, regulatory teams wonder:

  • Which deficiencies have we missed?
  • Which claims are insufficiently supported?
  • Which inconsistencies remain hidden?
  • What will trigger additional review rounds?

You only discover the answers after submission.
Studia helps identify them beforehand.

A single observation can trigger months of delay

01Submission
02NB Review
03Deficiency Letter
04Internal Investigation
05Document Updates
06Additional Review Cycle

Consequences

  • 3 to 9 months delay
  • Additional consultant costs
  • Team distraction
  • Delayed market access
  • Increased regulatory uncertainty

Most deficiencies originate in documentation.
Not product performance.

Notified Bodies review entire systems, not individual documents

CER is not reviewed alone.CIP is not reviewed alone.The Risk File is not reviewed alone.

Reviewers assess:

  • Consistency
  • Traceability
  • Clinical justification
  • Risk alignment
  • Evidence quality

A perfectly written document can still fail if it contradicts the rest of the submission package.

What Notified Bodies commonly challenge

The same categories appear repeatedly across reviews.

Clinical Evidence

Insufficient support for safety or performance claims.

Traceability

Missing links between claims and underlying evidence.

Risk Management

Clinical conclusions not aligned with identified risks.

PMCF

Weak post-market clinical follow-up evidence strategy.

Benefit-Risk

Conclusions not fully supported by available data.

Clinical Investigation Plans

Insufficient endpoint rationale or methodological justification.

Traditional readiness reviews have limits

Human expertise remains essential, but human review faces real constraints:

  • Thousands of pages
  • Multiple contributors
  • Multiple versions
  • Tight timelines

Even excellent consultants cannot systematically compare every statement across every document.
Studia can.

A regulatory copilot designed around reviewer logic

Studia evaluates documents through the lens of a regulatory reviewer, creating an additional review layer before formal assessment.

The platform searches for

  • Missing information
  • Contradictions between documents
  • Unsupported claims
  • Traceability gaps
  • Incomplete justification

Studia continuously asks

  • “Where is the evidence?”
  • “Is this conclusion justified?”
  • “Does the risk file support this statement?”
  • “Is the PMCF strategy aligned?”
  • “Is this endpoint appropriately justified?”

The real source of many findings

Each document may appear acceptable independently. Together they create a review finding.

CER conclusion

“The device demonstrates acceptable safety.”

Risk Management File

Residual risk remains significant.

PMCF Plan

No strategy to collect additional evidence.

Studia evaluates these relationships automatically.

Know where you stand before submission

Studia generates structured assessments across the dimensions reviewers prioritise.

01Clinical evidence strength
02Traceability
03Risk alignment
04Documentation completeness
05PMCF robustness
06ISO 14155 compliance

Result: a prioritised roadmap of issues requiring attention before submission.

Designed around current and emerging expectations

  • MDR requirements
  • IVDR requirements
  • MEDDEV principles
  • ISO 14155:2026 updates
  • Clinical evaluation best practices

The platform evolves alongside the regulatory environment.

Human experts remain in control

Studia does not replace Regulatory Affairs, Clinical Affairs, Quality teams, or consultants. It amplifies them.

✓Reviewable
✓Traceable
✓Auditable
✓Explainable

The final decision always belongs to the regulatory team.

Fewer questions. Faster reviews. Stronger submissions.

The ideal submission is not the one that gets approved.
The ideal submission is the one that generates the fewest questions.

From

Reactive response to deficiencies

→
To

Proactive readiness before submission

Reduce Notified Body surprises before they happen.

Talk to the team

Built for regulated industries

ISO 27001
SOC 2 Type II
HIPAA
GDPR
EU AI Act

Hosted in the EU, the US or APAC, or on-premise, wherever your organization needs it

Our Mission

We are dedicated to helping patients worldwide by accelerating clinical studies.

We streamline medical writing and regulatory documentation to bring life-saving drugs and medical devices to market faster. Every day saved in the approval process means more patients can access innovative treatments sooner.

Ready to replace Word?

Our clients write their documents 50 to 80% faster with Studia. Schedule a demo or get in touch with our Sales Team.

Contact our Sales Team

Tell us about your studies and documents, and we will get back to you.

sales@studia.health